RegenMed Investment Theses Webinar Recording Now Available

December 12, 2024

Share This Page
View as PDF

RegenMed Investment Theses Webinar Recording Now Available

December 12, 2024

On November 12, RegenMed’s CEO and Co-Founder Michael P. Tierney conducted a webinar discussing the Company’s investment theses and global traction.  The webinar recording has been divided into ten chapters, now available on the Company’s Investors Page.

Share This Page

RegenMed Investment Theses Webinar Recording Now Available

December 12, 2024

On November 12, RegenMed’s CEO and Co-Founder Michael P. Tierney conducted a webinar discussing the Company’s investment theses and global traction.  The webinar recording has been divided into ten chapters, now available on the Company’s Investors Page.

Share This Page

Read The Latest

January 16, 2025

RegenMed Attacks The Physical Therapy Data Market

Discover how Physicians-Owned Circles are revolutionizing the $50 billion physical therapy market by generating high-value datasets and enhancing treatment practices amid rising demand.

January 14, 2025

Real-World Data Licensing: A Large Opportunity for RegenMed

The healthcare data analytics market is worth $64 billion, with a forecasted 21% annual growth. At the same time, there is a strong focus on the importance of real-world data. Through its patented Circles platform, RegenMed is well positioned to exploit both of these powerful trends...

January 8, 2025

RegenMed Expectations 2025

The December 16, 2024 Investors Webinar, led by CEO Michael Tierney, highlighted RegenMed's 2025 growth plans and increasing demand for real-world evidence datasets. The company aims to scale rapidly in large markets, drawing parallels with successful SaaS exits.